Rocket Lab USA (RKLB) is growing fast. In Q2, the company’s revenue jumped 62%, while its backlog reached $2.36 billion, showing strong demand for its space systems and launch services. But that growth comes with risks investors need to watch. TipRanks’ Risk Analysis tool flags 72 risk factors for RKLB. Financial and Production risks matter most, as they make up the largest share of Rocket Lab’s overall risk profile. Wall Street remains bullish on RKLB, with a Strong Buy rating and a $110.93 average price target, implying 35% upside. Still, investors should weigh the key risks behind that growth.
Summer Sale - Claim 70% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
For context, public companies disclose key risks in their SEC filings. They first report them in S-1 filings during an IPO, then update them in annual 10-K or 20-F reports. Meanwhile, quarterly 10-Q filings highlight any major changes. TipRanks’ Risk Analysis tool makes this information easier for investors to review by organizing key risk factors and showing where the main risks lie.
Rocket Lab Risk Analysis
Rocket Lab is a space launch company focused on small orbital rockets and satellite solutions. It is best known for its Electron rocket and its upcoming Neutron launch vehicle. Neutron is designed to carry larger payloads than Electron and could create a new growth opportunity for Rocket Lab.
According to TipRanks’ Risk Analysis Tool, Finance & Corporate risks make up 38% of Rocket Lab’s total risk, above the sector average of 33.5%. Production risk follows at 24%, also higher than the sector average of 19.4%.

Other risk areas, including Legal & Regulatory, Tech & Innovation, Ability to Sell, and Macro & Political, are below their respective sector averages.
Looking at the risk trend, RKLB’s total risk factors jumped 16% from 62 at the end of Q1 2026 to 72 in Q2 2026. This increase suggests that the company’s risk profile has become more significant as it continues to invest in growth.

Rocket Lab’s Risk Breakdown
Financial Risks:
Rocket Lab’s pending $8 billion acquisition of Iridium Communications (IRDM) marks a major shift for the company. The deal could expand Rocket Lab beyond launch and space hardware into a broader space communications business. However, it also brings higher debt, potential share dilution, and execution risks for RKLB investors.
- Share dilution: The Iridium deal could lead to a large number of new shares being issued, which could put pressure on RKLB’s stock price.
- Debt risk: The company plans to use debt to help fund the cash part of the deal. If that funding is not available when needed, the deal could face delays.
- Integration risk: Rocket Lab may not achieve the expected cost savings or growth benefits from combining with Iridium. The integration could also cost more or take longer than planned.
- Deal risk: The transaction still depends on certain conditions being met. If they are not, the deal could be delayed or even terminated.
Production Risks:
- Neutron Delay: Production risk is a key concern for Rocket Lab, especially with the tight timeline for its Neutron rocket. The first Neutron launch could slip into 2027, while the company targets late 2026 for the rocket to reach the launch pad. Testing setbacks, including tank structural issues, have added to the pressure. A delay could push back revenue from Neutron and add to development costs, making the Production risk flagged by TipRanks more relevant for RKLB investors.
Is RKLB a Good Stock to Buy?
According to TipRanks, RKLB stock has received a Strong Buy consensus rating, with 12 Buys and four Holds assigned in the last three months. The average price target for Rocket Lab is $110.93, suggesting a potential upside of 35% from the current level.
Year-to-date, RKLB stock has gained 17.6%.


